High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.6M
$1,641,552
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
Sell to Cover
2026-03-02
$220,943x3
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $220,943x3 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
10b5-1 Sell
2026-02-27
$92,934
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2026-02-27 | $92,934 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
Sell to Cover
2026-02-02
$1,027,293Largex4
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-02-02 | $1,027,293Largex4 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
10b5-1 Sell
2025-12-01
$50,091
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-12-01 | $50,091 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
Sell to Cover
2025-11-19
$72,135x2
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-11-19 | $72,135x2 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
Sell to Cover
2025-11-03
$178,156x2
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-11-03 | $178,156x2 | S | Form 4 |